نتائج البحث

اذهب إلى التنقل اذهب إلى البحث
  • * [[صياغة صيدلانية]] pharmaceutical formulation
    2 كيلوبايت (12 كلمة) - 18:37، 29 يوليو 2011
  • ...]] into the body after being applied to the skin in the form of a [[cream (pharmaceutical)|cream]], [[gel]] or [[lotion]]. [[Transdermal patch]]es have become a popu ...azole]] antifungal cream might irritate the skin less than an athlete foot formulation of miconazole cream. These variations can, on occasion, result in different
    14 كيلوبايت (2٬121 كلمة) - 11:48، 14 أبريل 2013
  • ...substances have [[medication|medicinal]] properties, they are considered [[Pharmaceutical drug|pharmaceuticals]]. The field encompasses [[drug]] composition and prop ...diation]]. Human health and ecology is intimately related. Demand for more pharmaceutical products may place the public at risk through the destruction of species. T
    24 كيلوبايت (2٬622 كلمة) - 21:13، 11 سبتمبر 2012
  • ==تطوير التركيبات FORMULATION DEVELOPMENT== ==صياغة القشرة Shell Formulation==
    66 كيلوبايت (1٬422 كلمة) - 08:00، 5 مايو 2016
  • ...rard, B (2003). "Systematic characterization of oil-in-water emulsions for formulation design". International Journal of Pharmaceutics 263 (1-2): 85. [[:en:Digita ...e; Gref, Ruxandra (2003). "Novel polyester-polysaccharide nanoparticles.". Pharmaceutical Research 20 (8): 1284.[[:en:Digital object identifier|doi:]][http://www.spr
    38 كيلوبايت (1٬191 كلمة) - 05:37، 2 نوفمبر 2013
  • ...emisynthesis|semi-synthetic]] process is the primary source of codeine for pharmaceutical use. It is considered the prototype of the weak to midrange [[opioids]] ([[ ...roducts Containing Codeine: Draft Guidance for Pharmacists | publisher = [[Pharmaceutical Society of Ireland]]}}</ref>
    52 كيلوبايت (6٬316 كلمة) - 13:05، 3 أغسطس 2013
  • FORMULATION FACTORS AFFECTING DRUG ABSORPTION AND ABSORPTION *عوامل الصياغة (المستحضرات): Formulation Factors
    87 كيلوبايت (549 كلمة) - 19:15، 19 ديسمبر 2015
  • ...rld Health Organization]] | title = International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 83 | journal = WHO Drug Information | ...KT | title = Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations | journal = Clin Ther | volume = 27 | issue = 11 | pages = 1
    75 كيلوبايت (3٬780 كلمة) - 17:27، 2 يونيو 2016